Gelonghui March 20 | FuRui Medical Technology (01696.HK) announced that for the year ended December 31, 2023, the company's revenue was 359.3 million US dollars, an increase of 1.4% over last year's revenue. Gross margin increased from 57.0% in the same period in 2022 to 61.1% in the reporting period. Net cash flow from operating activities for the year was $43.9 million, up 99.4% from last year's net cash flow from operating activities.
Profit for the year decreased by 17.9% to $32.9 million from $40.1 million in the same period in 2022. The board of directors decided to pay a final dividend of HK$0.158 per share (tax included).